درباره این اپیزود
Prof Gilles Vassal - University Paris-Sud, Orsay, France
Prof Vassal talks to ecancertv at ECC 2015 about research looking at expanding patient access to crizotinib and the work of the AcSé Program initiated by the French National Cancer Institute.
Crizotinib is currently only approved for use in patients with ALK-positive nonsmall-cell lung cancer. As it also targets MET and ROS1, however, it has the potential to be used in many more malignancies that affect both adults and children.
Prof Vassal discusses the results of a 5284-patient trial that was conducted across 168 centres in which a biomarker-driven approach was used to identify and then treat tumours expressing the three genetic targets of crizotinib.
Prof Vassal talks to ecancertv at ECC 2015 about research looking at expanding patient access to crizotinib and the work of the AcSé Program initiated by the French National Cancer Institute.
Crizotinib is currently only approved for use in patients with ALK-positive nonsmall-cell lung cancer. As it also targets MET and ROS1, however, it has the potential to be used in many more malignancies that affect both adults and children.
Prof Vassal discusses the results of a 5284-patient trial that was conducted across 168 centres in which a biomarker-driven approach was used to identify and then treat tumours expressing the three genetic targets of crizotinib.
انگلیسی
ایالات متحده آمریکا
رونوشت 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
جستجوی اپیزودهای گذشته
اپیزودهای قبلی ECC 2015 را جستجو کن.
قسمت های دیگر در این پادکست
Prof Peter Naredi - University of Gothenburg, Gothenburg, Sweden
Prof Naredi talks to ecancertv at ECC 2015 about the use of surgery in synchronous oligometastatic disease.
In the interview he highlights that two to three decades ago it was rare that patients with metastatic disease would be refe…
Prof Priscilla Brastianos - Massachusetts General Hospital, Boston, USA
Prof Brastianos talks to ecancertv at ECC 2015 about how unravelling the genetic sequences of cancer that has spread to the brain could offer unexpected targets for treatment.
In the interview she highlights the results of a …
Prof Martin Schrappe - University Medical Center Schleswig-Holstein, Kiel, Germany
Prof Schrappe talks to ecancertv at ECC 2015 about improving both the cure rate and the quality of life for survivors of childhood cancers over the next ten years, with the ultimate aim of increasing disease-free an…
Prof Mark Lawler - Chair of the EAPM Research Subgroup
Prof Lawler talks to ecancertv at ECC 2015 about his investigation into disparities across Europe.
He discusses what discoveries he has made, and how economics and resources can affect treatment of cancer patients.
Prof Riccardo Audisio - President of the European Society for Surgical Oncology
Prof Audisio talks to ecancertv at ECC 2015 about optimising education about cancer surgery and the need to improve current standards as only 25% of patients receive adequate surgical care.
He also talks about the tre…
سلب مسئولیت: پادکست و آثار هنری تعبیه شده در این صفحه متعلق به ecancer.org است که متعلق به صاحب آن است و به Listen Notes، Inc وابسته یا تایید نشده است.
ویرایش
از کمک شما برای بروز نگهداشتن پایگاهدادههای پادکست سپاسگزاریم
